The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge incontinence, a stigmatized condition, by gently stimulating a nerve inside the ankle.
Patient BMI did not affect treatment outcomes across several efficacy measures among patients with AD who were treated with JAK inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback